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The fraction of influenza virus infections that are 
asymptomatic: a systematic review and meta-analysis 
Nancy H. L. Leung1*, Cuiling Xu1, Dennis K. M. Ip1, Benjamin J. Cowling1 
1School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China. 
Background 
     Influenza virus infections lead to a wide range of clinical manifestations, from severe pneumonia through to subclinical or 
even asymptomatic disease. There has been substantial controversy over the proportion of influenza virus infections that are 
asymptomatic, referred to as the asymptomatic fraction (AF). Knowledge on the AF, variation in the AF in certain groups, and 
the potential infectiousness of asymptomatic cases is extremely important in designing public health control strategies such as 
contact tracing and quarantine, and in estimating the burden of disease. 
Objectives 
     In this study, we aim  to describe and summarize published estimates of the asymptomatic fraction (AF). 
Methods 
     We conducted a systematic review to assess and summarize the AF of influenza virus infections. Studies containing data 
on asymptomatic fraction of influenza virus were retrieved from the PubMed electronic databases on 11 April 2014. 
Laboratory-confirmed influenza infection was defined as an infection confirmed by RT-PCR or viral culture test result on a 
respiratory specimen; or serologic evidence of recent infection indicated by a ≥ 4-fold rise in antibody titer in paired sera, or 
≥1:40 titer in a single serum specimen. Asymptomatic illness was defined as specified by the respective studies. The AF in our 
study was defined as the proportion of influenza-infected individuals that reported no symptomatic illness, and was calculated 
for each study with a 95% confidence interval. Heterogeneity was estimated using the I2 statistic with a random-effects model.  
Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     463 titles were retrieved and screened, 110 abstracts and 68 full-length articles were then reviewed. 30 articles were 
identified and classified into two categories: outbreak investigations (11) and trans-epidemic studies (19). 
     Studies in the group of outbreak investigations included outbreak investigations in specific settings such as households. In 
these studies, respiratory secretions were usually collected and the acute infections were confirmed by RT-PCR or viral culture 
during intensive follow-up efforts with repeat collection of respiratory specimens from symptomatic and asymptomatic 
individuals. Point estimates of the AF from these studies fell within the range 8%-28% or had wide confidence intervals 
extending into this range (Figure 1A). Heterogeneity measured by the I2 statistic was medium (61%). 
     The other studies could be grouped together as serological studies where individuals were followed up across entire 
epidemics, and testing of single or paired sera was used to identify infections. Illness reports in the same individuals could 
then be used to infer how many influenza virus infections might have been symptomatic. Overall, point estimates of the AF 
from this group of studies spread across a wide range of 0%-93% with very high heterogeneity (I2=97%) (Figure 1B and 1C). 
Five estimates have been adjusted for rates of illness from other non-influenza causes with estimates in the range 65%-85% 
(Figure 1B), and were higher than most of the unadjusted estimates (Figure 1C). There was also less heterogeneity among 
the studies that reported adjusted estimates, with I2 statistics of 58% for adjusted versus 98% for unadjusted estimates.  
Conclusions 
     The true AF of influenza virus infections is likely to fall somewhere between the 8%-28% reported in outbreak studies and 
the 65%-85% reported in adjusted estimates from serologic studies. Variation in estimates could be partially explained by 
differences in study design and analysis, and inclusion of mild symptomatic illnesses as asymptomatic in some studies. 
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Figure 1. Forest plot of estimates of the asymptomatic fraction, stratified by study design. A. Estimates from outbreak 
investigations. B and C. Estimates from trans-epidemic studies, with adjustment for rates of symptomatic illness in uninfected 
persons (B), or not (C).  
